Log In
Print
BCIQ
Print
Print this Print this
 

OpRegen

  Manage Alerts
Collapse Summary General Information
Company Cell Cure Neurosciences Ltd.
DescriptionHuman embryonic stem cell-derived retinal pigmented epithelial (RPE) cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat dry age-related macular degeneration (AMD) with geographic atrophy (GA); Treat geographic atrophy (GA) associated with dry or non-neovascular age-related macular degeneration (AMD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today